Search Results - Noriko Yanagitani

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Association of the <i>OGG1</i>‐Ser326Cys polymorphism with lung adenocarcinoma risk

    Association of the <i>OGG1</i>‐Ser326Cys polymorphism with lung adenocarcinoma risk by Takashi Kohno, Hideo Kunitoh, Kaoru Toyama, Seiichiro Yamamoto, Aya Kuchiba, Daizo Saito, Noriko Yanagitani, Shinichi Ishihara, Ryusei Saito, Jun Yokota

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy

    Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy by Ryo Ariyasu, Atsushi Horiike, Takahiro Yoshizawa, Yosuke Dotsu, Junji Koyama, Masafumi Saiki, Tomoaki Sonoda, Shingo Nishikawa, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Impact of immune-related adverse event severity on overall survival in patients with advanced NSCLC receiving immune checkpoint inhibitors therapy, with a focus on combination regimens

    Impact of immune-related adverse event severity on overall survival in patients with advanced NSCLC receiving immune checkpoint inhibitors therapy, with a focus on combination regi... by Mayu Sugai, Yoshiaki Amino, Seitaro Fujishima, Kyujiro Nibuya, Hirokazu Iso, Masahiro Ito, Ryosuke Tsugitomi, Ryo Ariyasu, Ken Uchibori, Noriko Yanagitani, Makoto Nishio

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Prognostic significance of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung

    Prognostic significance of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung by Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, Kimihiro Shimizu, Noriko Yanagitani, Noriaki Sunaga, Takeshi Hisada, Tamotsu Ishizuka, Yoshikatsu Kanai, Hitoshi Endou, Takashi Nakajima, Masatomo Mori

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

    Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer by Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, Kimihiro Shimizu, Noriko Yanagitani, Noriaki Sunaga, Takeshi Hisada, Shigebumi Tanaka, Tamotsu Ishizuka, Yoshikatsu Kanai, Hitoshi Endou, Takahiro Nakajima, Masatomo Mori

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    <scp>l</scp>‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms

    <scp>l</scp>‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms by Kyoichi Kaira, Noboru Oriuchi, Hisao Imai, Kimihiro Shimizu, Noriko Yanagitani, Noriaki Sunaga, Takeshi Hisada, Shigebumi Tanaka, Tamotsu Ishizuka, Yoshikatsu Kanai, Hitoshi Endou, Takashi Nakajima, Masatomo Mori

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Detection of epidermal growth factor receptor T790M mutation in plasma <scp>DNA</scp> from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor

    Detection of epidermal growth factor receptor T790M mutation in plasma <scp>DNA</scp> from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor by Kazuko Sakai, Atsushi Horiike, Darryl Irwin, Keita Kudo, Yoshihiko Fujita, Azusa Tanimoto, Toshio Sakatani, Ryota Saito, Kyohei Kaburaki, Noriko Yanagitani, Fumiyoshi Ohyanagi, Makoto Nishio, Kazuto Nishio

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms

    Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms by Noriko Yanagitani, Ken Uchibori, Sumie Koike, Mika Tsukahara, Satoru Kitazono, Takahiro Yoshizawa, Atsushi Horiike, Fumiyoshi Ohyanagi, Yuichi Tambo, Shingo Nishikawa, Naoya Fujita, Ryohei Katayama, Makoto Nishio

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer

    Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer by Bo Gong, Kazuma Kiyotani, Seiji Sakata, Seiji Nagano, Shun Kumehara, Satoko Baba, Benjamin Besse, Noriko Yanagitani, Luc Friboulet, Makoto Nishio, Kengo Takeuchi, Hiroshi Kawamoto, Naoya Fujita, Ryohei Katayama

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study

    Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results fro... by David Planchard, Po‐Hao Feng, Nina Karaseva, S.-W. Kim, T.M. Kim, Chee Khoon Lee, Artem Poltoratskiy, Noriko Yanagitani, Ryan Marshall, X. Huang, Paul Howarth, Pasi A. Jänne, Kunihiko Kobayashi

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

    Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy by Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori, John D. Minna

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Association of amino acid substitution polymorphisms in DNA repair genes <i>TP53</i>, <i>POLI</i>, <i>REV1</i> and <i>LIG4</i> with lung cancer risk

    Association of amino acid substitution polymorphisms in DNA repair genes <i>TP53</i>, <i>POLI</i>, <i>REV1</i> and <i>LIG4</i> with lung cancer risk by Tokuki Sakiyama, Takashi Kohno, Sachiyo Mimaki, Tsutomu Ohta, Noriko Yanagitani, Tomotaka Sobue, Hideo Kunitoh, Ryusei Saito, Kimiko Shimizu, Chie Hirama, Junko Kimura, Go Maeno, Hiroshi Hirose, Takashi Eguchi, Daizo Saito, Misao Ohki, Jun Yokota

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <i>EGFR</i> Mutations

    Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <i>EGFR</i> Mutations by Satoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, Koichi Yamazaki, Hajime Asahina, Akira Inoue, Koichi Hagiwara, Noriaki Sunaga, Noriko Yanagitani, Toyoaki Hida, Kimihide Yoshida, Tomonori Hirashima, Kosei Yasumoto, Kenji Sugio, Tetsuya Mitsudomi, Masahiro Fukuoka, Toshihiro Nukiwa

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance

    Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance by Koutaroh Okada, Mitsugu Araki, Takuya Sakashita, Biao Ma, Ryo Kanada, Noriko Yanagitani, Atsushi Horiike, Sumie Koike, Tomoko Oh‐hara, Kana Watanabe, Keiichi Tamai, Makoto Maemondo, Makoto Nishio, Takeshi Ishikawa, Yasushi Okuno, Naoya Fujita, Ryohei Katayama

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation

    Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation by Ray Sagawa, Seiji Sakata, Bo Gong, Yosuke Seto, Ai Takemoto, Satoshi Takagi, Hironori Ninomiya, Noriko Yanagitani, Masayuki Nakao, Mingyon Mun, Ken Uchibori, Makoto Nishio, Yasunari Miyazaki, Yuichi Shiraishi, Seishi Ogawa, Keisuke Kataoka, Naoya Fujita, Kengo Takeuchi, Ryohei Katayama

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of <i>ALK</i> Mutation Status

    Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of <i>ALK</i> Mutation Status by Koji Fukuda, Shinji Takeuchi, Sachiko Arai, Ryohei Katayama, Shigeki Nanjo, Azusa Tanimoto, Akihiro Nishiyama, Takayuki Nakagawa, Hirokazu Taniguchi, Takeshi Suzuki, Tadaaki Yamada, Hiroshi Nishihara, Hironori Ninomiya, Yuichi Ishikawa, Satoko Baba, Kengo Takeuchi, Atsushi Horiike, Noriko Yanagitani, Makoto Nishio, Seiji Yano

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

    P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer by Ryohei Katayama, Takuya Sakashita, Noriko Yanagitani, Hironori Ninomiya, Atsushi Horiike, Luc Friboulet, Justin F. Gainor, Noriko Motoi, Akito Dobashi, Seiji Sakata, Yuichi Tambo, Satoru Kitazono, Shigeo Sato, Sumie Koike, A. John Iafrate, Mari Mino‐Kenudson, Yuichi Ishikawa, Alice T. Shaw, Jeffrey A. Engelman, Kengo Takeuchi, Makoto Nishio, Naoya Fujita

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

    The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models by Ryohei Katayama, Bo Gong, Noriko Togashi, Masaya Miyamoto, Masaki Kiga, Shiho Iwasaki, Yasuki Kamai, Yuichi Tominaga, Yasuyuki Takeda, Yoshiko Kagoshima, Yuki Shimizu, Yosuke Seto, Tomoko Oh‐hara, Sumie Koike, Naoki Nakao, Hiroyuki Hanzawa, Kengo Watanabe, Satoshi Yoda, Noriko Yanagitani, Aaron N. Hata, Alice T. Shaw, Makoto Nishio, Naoya Fujita, Takeshi Isoyama

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer

    Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer by Hayato Mizuta, Koutaroh Okada, Mitsugu Araki, Jun Adachi, Ai Takemoto, Justyna Kutkowska, Kohei Maruyama, Noriko Yanagitani, Tomoko Oh‐hara, Kana Watanabe, Keiichi Tamai, Luc Friboulet, Kazuhiro Katayama, Biao Ma, Yoko Sasakura, Yukari Sagae, Mutsuko Kukimoto‐Niino, Mikako Shirouzu, Satoshi Takagi, Siro Simizu, Makoto Nishio, Yasushi Okuno, Naoya Fujita, Ryohei Katayama

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

    The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer by Luc Friboulet, Nanxin Li, Ryohei Katayama, Christian C. Lee, Justin F. Gainor, Adam S. Crystal, Pierre‐Yves Michellys, Mark M. Awad, Noriko Yanagitani, Sung Joon Kim, AnneMarie Culazzo Pferdekamper, Jie Li, Shailaja Kasibhatla, Frank F. Sun, Xiuying Sun, Su Hua, Peter McNamara, Sidra Mahmood, Elizabeth L. Lockerman, Naoya Fujita, Makoto Nishio, Jennifer L. Harris, Alice T. Shaw, Jeffrey A. Engelman

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: